Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HMGCR | P04035 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28948545 | 1.00 | TSHR (0.41) | TSHRALDH1A1HMGCRCHRM1TBXA2R | |
| SCHEMBL29799742 | 1.00 | TSHR (0.41) | TSHRALDH1A1HMGCRCHRM1TBXA2R | |
| SCHEMBL1784246 | 0.80 | ALDH1A1 (0.31) | TSHRALDH1A1PIK3CD | |
| SCHEMBL28985884 | 0.78 | TSHR (0.39) | TSHRALDH1A1HMGCRCHRM1TBXA2R | |
| SCHEMBL1300987 | 0.78 | TSHR (0.39) | TSHRALDH1A1HMGCRCHRM1TBXA2R | |
| SCHEMBL25269145 | 0.78 | CA2 (0.47) | CA2MAPK1 | |
| SCHEMBL9619838 | 0.77 | TSHR (0.36) | TSHRALDH1A1HMGCRCHRM1TBXA2R | |
| SCHEMBL5369984 | 0.77 | TSHR (0.36) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL5718396 | 0.77 | TSHR (0.36) | TSHRALDH1A1HMGCRCHRM1TBXA2R | |
| SCHEMBL1572815 | 0.77 | TSHR (0.36) | TSHRALDH1A1CYP2D6CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240397944-A1 | METHODS FOR BIOFILM DISRUPTION | Lixa Limited (AU) | 2024-12-05 | — | — | US | disclosed |
| US-20240110101-A1 | Ferroelectric liquid crystal (FLC) material and chiral compound | SANMA ELETRON (HONG KONG) APPLIANCE COMPANY LIMITED (HK) | 2024-04-04 | — | — | US | disclosed |
| EP-3661901-B1 | SYNTHESIS OF GLYCOLS VIA TRANSFER HYDROGENATION OF ALPHA-FUNCTIONAL ESTERS WITH ALCOHOLS | EASTMAN CHEM CO (US) | 2023-12-06 | — | — | EP | disclosed |
| CN-109996865-B | Formation of alkenes by enzymatic dehydration of alkanols | 布拉斯肯有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-109312373-B | Microorganisms and methods for co-production of ethylene glycol and three carbon compounds | 布拉斯肯有限公司 | 2022-07-19 | — | — | CN | disclosed |
| US-10266467-B2 | Synthesis of glycols via transfer hydrogenation of alpha-functional esters with alcohols | EASTMAN CHEMICAL COMPANY (US) | 2019-04-23 | — | — | US | disclosed |
| US-20190039978-A1 | SYNTHESIS OF GLYCOLS VIA TRANSFER HYDROGENATION OF ALPHA-FUNCTIONAL ESTERS WITH ALCOHOLS | EASTMAN CHEMICAL COMPANY (US) | 2019-02-07 | — | — | US | disclosed |
| US-20150240272-A1 | LACTATE PRODUCTION PROCESS | PLAXICA LIMITED (GB) | 2015-08-27 | — | — | US | disclosed |
| WO-2014045036-A1 | LACTATE PRODUCTION PROCESS | PLAXICA LIMITED (GB) | 2014-03-27 | — | — | WO | disclosed |
| EP-1961739-B1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | JSR CORP (JP) | 2012-10-17 | — | — | EP | disclosed |
| US-8273837-B2 | Compound, polymer, and resin composition | JSR CORPORATION (JP) | 2012-09-25 | — | — | US | disclosed |
| US-20090318652-A1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | JSR CORPORATION (JP) | 2009-12-24 | — | — | US | disclosed |
| US-20090305161-A1 | LIQUID IMMERSION LITHOGRAPHY | JSR CORPORATION (JP) | 2009-12-10 | — | — | US | disclosed |
| EP-1961739-A1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | JSR Corporation (JP) | 2008-08-27 | — | — | EP | disclosed |
| EP-1953595-A1 | RADIATION-SENSITIVE RESIN COMPOSITION | JSR Corporation (JP) | 2008-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318652-A1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | ERCC4, RAD51, RTF1 | TSHR 4489/4885ALDH1A1 4177/4885HMGCR 4364/4885 |
| US-20190039978-A1 | SYNTHESIS OF GLYCOLS VIA TRANSFER HYDROGENATION OF ALPHA-FUNCTIONAL ESTERS WITH ALCOHOLS | ADH1A, ADH1C, ADH5 | TSHR 3066/4885ALDH1A1 270/4885HMGCR 287/4885 |
| US-20240397944-A1 | METHODS FOR BIOFILM DISRUPTION | FGB, MMP8, HAO2 | TSHR 4619/4885ALDH1A1 431/4885HMGCR 1193/4885 |
| US-10266467-B2 | Synthesis of glycols via transfer hydrogenation of alpha-functional esters with alcohols | ADH1A, ADH1C, ADH5 | TSHR 3066/4885ALDH1A1 270/4885HMGCR 287/4885 |
| US-20240110101-A1 | Ferroelectric liquid crystal (FLC) material and chiral compound | CRY1, CRY2, NOTCH4 | TSHR 1824/4885ALDH1A1 4878/4885HMGCR 1339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.